Remarkable Improvement in a Patient with Schizophrenia and Prominent Negative Symptoms after Adding-on Mirtazapine to Amisulpride

併有明顯負性症狀之思覺失調症病人使用Amisulpride在輔以Mirtazapine後顯著的改善

陳昱安(Yu-An Chen)；張正辰(Cheng-Chen Chang)；黃斯聖(Si-Sheng Huang)

台灣精神醫學

29卷4期（2015 / 12 / 01）

273 - 275

英文

1. American Psychiatric Association(2013).Diagnostic and Statistical Manual of Mental Disorders.Arlington, Virginia, USA:American Psychiatric Association.
2. Arborelius, L,Nomikos, GG,Hertel, P(1996).The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.Naunyn Schmiedebergs Arch Pharmacol,353,630-640.
3. Hasan, A,Falkai, P,Wobrock, T(2013).World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.World J Biol Psychiatry,14,2-44.
4. Millan, MJ,Dekeyne, A,Gobert, A(1998).Serotonin (5-HT) 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.Neuropharmacology,37,953-955.
5. Shen, WW(2011).Clinical Psychopharmacology for the 21st Century.Taipei:HoChi Publishing Company.
6. Siris, SG(1994).Assessment and treatment of depression in schizophrenia.Psychiatric Ann,24,463-467.
7. Wiker, C,Linnér, L,Wadenberg, ML,Svensson, TH(2005).Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect.Neuropsychiatr Dis Treat,1,356.